Search
for
Sort by
Research 91–120 of 137
- Omenn syndrome in a 10-month-old male with athymia and VACTERL association
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Cutaneous signals of immune system disease
- Decision‐Making Regarding the Administration of Live Vaccines to Patients With a <i>FOXN1</i> Heterozygous Missense Variant
- Immunology of the Human Nail Apparatus: The Nail Matrix Is a Site of Relative Immune Privilege
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- P131 Menstrual irregularity in hirsute women
- Immunoregulatory mechanisms and stress hormones in psoriasis (part 1)
- Virilizing insulinoma
- A Contemporary View on Felix Pinkus’ Concept of the Vitreous Membrane
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations
- Laparoscopic Extirpation of Adrenal Gland Ganglioneuroma Incidentally Diagnosed during Evaluation for Patchy Alopecia Areata in an Adolescent Boy
- Multiple Myeloma–Associated Amyloidosis Presenting With Acrolocalized Acquired Cutis Laxa
- Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- A missing piece: the spiny mouse and the puzzle of menstruating species
- Human placenta hydrolysates: from V.P. Filatov to the present day: Review
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- 700 Tyrosine kinase 2 inhibition rescues hair follicles from IL-12–mediated immune privilege collapse and reverses the induction of human alopecia areata in a humanized mouse model
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- Overview of Alopecia Areata
- Type 1 interferon signature and cytotoxic T lymphocyte activation targeted against sweat ducts in inflammatory acquired idiopathic generalized anhidrosis
- Mimicking fat grafting of fibrotic scars using 3D‐organotypic skin cultures
- Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Alopecia Areata in Twins With Autoimmune Thyroiditis: Personal Observations